PRPriyanka

Priyanka

*This is an algorithmically generated author record based on publicly available information.

Priyanka has a total of 1 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Hemodynamic-Enzymatic Axis: The Interplay of Mean Arterial Pressure and Renalase in Diabetic Kidney Disease and Diabetic Foot Ulcers

    by Priyanka, Jayanthi R

    Background & Objective: The global burden of Diabetes Mellitus (DM) has transitioned into a systemic crisis characterized by Diabetic Kidney Disease (DKD) and Diabetic Foot Ulcers (DFU). This study investigates the heart-kidney-limb axis, specifically examining the role of Mean Arterial Pressure (MAP) and Serum Renalase as biomarkers for the transition from metabolic dysfunction to irreversible microvascular damage and mechanical barotrauma. Methods: A cross-sectional study was conducted at a tertiary care hospital in South India from January to July 2025. 120 participants were divided into four groups (n=30 each): Control, Type 2 Diabetes (T2DM), DKD, and DFU. Clinical assessments included blood pressure (to calculate MAP), eGFR, HbA1c, HOMA-IR, and Serum Renalase. Statistical analysis utilized Pearson’s correlation and Receiver Operating Characteristic (ROC) curves to determine diagnostic accuracy. Results: A progressive increase in MAP, Serum Renalase, and HOMA-IR was observed across groups (p < 0.01). Serum Renalase showed a strong negative correlation with eGFR (r = -0.76, p < 0.001), supporting an Accumulation Paradox where levels rise as renal clearance fails. A positive correlation between MAP and Renalase (r = +0.62) suggested a Failed Feedback Loop. ROC analysis identified Serum Renalase as a superior biomarker for distinguishing DKD from T2DM (AUC = 0.92, Sensitivity 85–90%). MAP was highly specific for kidney involvement, with a threshold of 106.40 mmHg yielding 91% specificity for DKD. The DFU group exhibited the highest Renalase levels (39.4 ±5.2 mg/mL), correlating with Wagner Grade severity (r = +0.48). Conclusion: The study confirms that DKD and DFU are manifestations of a singular, systemic pro-inflammatory environment driven by a breakdown in the MAP-Renalase axis. Serum Renalase serves as a robust screening tool for microvascular stress, while MAP serves as a critical confirmatory marker for glomerular damage. Integrating these biochemical and hemodynamic markers provides a superior diagnostic framework for identifying patients at high risk for end-stage renal disease and limb amputation.